Immunodeficiency Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Immunodeficiency stocks.

Immunodeficiency Stocks Recent News

Date Stock Title
Apr 23 BMY S&P 500 stocks with biggest estimated EPS declines for Q1
Apr 23 BMY NeoGenomics (NEO) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Apr 23 GILD Gilead Q1 Earnings Preview: Most Gains Wiped Out - Cause For Concern?
Apr 23 INO Inovio Pharmaceuticals: The Dilution Continues
Apr 23 BMY Novartis Stock Gains On European Drugmaker's Q1 Earnings Surprise, Lifts Annual Outlook
Apr 23 BMY Former Bristol Myers CEO tapped as Novartis’ next board chair
Apr 22 SGMO Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Apr 22 HOOK Hookipa Pharma: 04/25/24 Update Should Be The First Of Several Positive Catalysts
Apr 22 GILD Gilead (GILD) Gears Up to Report Q1 Earnings: What to Expect?
Apr 22 BMY Bristol-Myers' (BMY) to Report Q1 Earnings: What You Should Know
Apr 22 GILD Gilead Sciences: Some Signs Of An Impending Bottom
Apr 22 BMY Bristol-Myers, Cellares ink $380M CAR-T therapies supply deal
Apr 22 BMY Is Bristol Myers Squibb A Buy At These Bottom Levels?
Apr 22 BMY Curious about Bristol Myers (BMY) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Apr 22 GILD Insights Into Gilead (GILD) Q1: Wall Street Projections for Key Metrics
Apr 22 BMY Bristol Myers taps startup to boost cell therapy production
Apr 22 BMY Bristol Myers Squibb and Cellares Announce a $380M Worldwide Capacity Reservation and Supply Agreement for the Manufacture of CAR T Cell Therapies to Bring the Promise of Cell Therapy to More Patients, Faster
Apr 21 GILD Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 21 BMY Can Magnificent 7 Help Script Market Turnaround? Earnings Pick Up Pace With Microsoft, Meta, Alphabet And Tesla Expected This Week
Apr 21 BMY Is Bristol-Myers Squibb (NYSE:BMY) Using Too Much Debt?
Immunodeficiency

Immunodeficiency, also known as immunocompromisation, is a state in which the immune system's ability to fight infectious diseases and cancer is compromised or entirely absent. Most cases are acquired ("secondary") due to extrinsic factors that affect the patient's immune system. Examples of these extrinsic factors include HIV infection and environmental factors, such as nutrition.
Immunocompromisation may also be due to genetic diseases/flaws. An example here is SCID.
In clinical settings, immunosuppression by some drugs, such as steroids, can either be an adverse effect or the intended purpose of the treatment. Examples of such use is in organ transplant surgery as an anti-rejection measure and in patients suffering from an overactive immune system, as in autoimmune diseases. Some people are born with intrinsic defects in their immune system, or primary immunodeficiency.A person who has an immunodeficiency of any kind is said to be immunocompromised. An immunocompromised individual may particularly be vulnerable to opportunistic infections, in addition to normal infections that could affect anyone. It also decreases cancer immunosurveillance, in which the immune system scans the body's cells and kills neoplastic ones.

Browse All Tags